4.7 Article

Anogenital Distance in Healthy Infants: Method-, Age- and Sex-related Reference Ranges

Journal

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
Volume 105, Issue 9, Pages 2996-3004

Publisher

ENDOCRINE SOC
DOI: 10.1210/clinem/dgaa393

Keywords

anogenital distance; reference ranges; endocrine disrupting chemicals; disorders of sexual development

Funding

  1. National Institute of Environmental Health Sciences [R01ES016863-04, R01 ES016863-02S4, P30 ES023515]
  2. European Union Framework V programme
  3. World Cancer Research Fund International
  4. Medical Research Council (UK)
  5. Newlife the Charity for Disabled Children
  6. Mothercare Group Foundation
  7. Mead Johnson Nutrition
  8. National Institute for Health Research Cambridge Comprehensive Biomedical Research Centre
  9. Danish Council for Independent Research medical sciences [4004-00352B_ FSS, 8020-00123B_FSS]
  10. Odense University Hospital
  11. Region of Southern Denmark
  12. Municipality of Odense
  13. Mental Health Service of the Region of Southern Denmark
  14. Odense University Hospital Research Foundation
  15. Odense Patient data Explorative Network (OPEN)
  16. Novo Nordisk Foundation [NNF15OC00017734, NNF17OC0029404]
  17. Helsefonden
  18. Rigshospitalet
  19. research foundation of Rigshospitalet
  20. Capital Region of Copenhagen
  21. Danish Environmental Agency
  22. International Research and Research Training Centre for Male Reproduction and Child Health (EDMaRC)
  23. Absalon Foundation

Ask authors/readers for more resources

Context: The use of anogenital distance (AGD) in clinical and epidemiological settings is increasing; however, sex-specific reference data on AGD and data on longitudinal changes in AGD in children is scarce. Objective: To create age-, sex-, and method-related reference ranges of AGD in healthy boys and girls aged 0-24 months, to assess the age-related changes in AGD and to evaluate the 2 predominantly used methods of AGD measurement. Design: The International AGD consortium comprising 4 centers compiled data from 1 cross-sectional and 3 longitudinal cohort studies (clinicaltrials.gov [NCT02497209]). Setting: All data were collected from population-based studies, recruiting from 4 maternity or obstetric centers (United States, Cambridge [United Kingdom], Odense, and Copenhagen [Denmark]). Subjects: This study included a total of 3705 healthy, mainly Caucasian children aged 0-24 months on whom 7295 measurements were recorded. Main Outcome Measures: AGD(AS) (ano-scrotal), AGD(AF) (ano-fourchette), AGD(AP) (ano-penile), AGD(AC) (ano-clitoral), AGD body size indices (weight, body mass index [BMI], body surface area, and length), and intra- and interobserver biases. Results: We created age-specific reference ranges by centers. We found that AGD increased from birth to 6 months of age and thereafter reached a plateau. Changes in AGD/BMI during the first year of life were minor (0-6% and 0-11% in boys and girls, respectively). Conclusions: Reference ranges for AGD can be used in future epidemiological research and may be utilized clinically to evaluate prenatal androgen action in differences-in-sex-development patients. The increase in AGD during the first year of life was age-related, while AGD/BMI was fairly stable. The TIDES and Cambridge methods were equally reproducible.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available